Stem Cell

AmnioFit AT Autologous Stem Cells Allogeneic Stem Cells
Procedure Consistent recover, processing, testing and storage. Easily administered in the doctors office. Recovered from bone marrow aspirates, adipose tissue or peripheral blood. Various techniques, processing, testing and infusion. May require significant patient monitoring during and after cell infusion.
Safety & Compliance Compliant under FDA regulations 21 CFR 1271. Ongoing clinical trials are providing additional safety and efficacy profiles. Varies on institution Varies on institution
Risks Minimal risk (Immunopriveleged.) Thousands of treatments and testimonials with minimal, if any, adverse reactions or side effects. Potential reaction to cryoprotectants. Potential immunity response or reaction to cryoprotectants. Unknown effects on patients.
Recovery Time Zero down time. Importantly, patient may go back to daily activities immediately, even increased activity. Patients undergo the initial procedure to recover the cells, then scheduled at a later time to have the cells infused. Patients may have to be hospitalized and monitored during and after infusion.
Contents Acellular. Contains Proteins (Cytokines, Chemokines, Growth Factors), Exosomes, Hyaluronic Acid. Available in 1.0, 2.0 & 3.0 mL Mesenchymal stem cells (MSCs). Additionally, cryoprotects and other preservatives that may dilute out the important functional contents. Mesenchymal (MSCs). Also, other preservatives that may dilute out the important functional contents. Various tissue materials with unknown effects.